APPLICATIONS PUBLISHED 1 JUNE 2005
Buccal, polar and non-polar spray or capsule containing drugs for treating mescular and skeletal disorders
Novadel Pharma 1534236*
Orally disintegrating tablets and processes for obtaining them
Vita Cientifica 1534237*
Formulations and dosage forms for controlled delivery of topiramate
Alza Corp 1534238*
Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole
Baxter Pharmaceuticals 1534239*
Colloidal drug carrier system
OctoPlus Sciences 1534240*
Transdermal aerosol compsns
Acrux DDS 1534241*
Buccal, polar or non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary system
Novadel Pharma 1543242*
Treating Alzheimer's using delipidated protein particles
Lipid Sciences 1534243*
Methods and compsns for treating benign gynaecological disorders, contraception and hormone replacement
Balance Pharmaceuticals 1534244*
Rapidly disintegrating tablet
LEK Pharmaceuticals 1534245*
Sustained release pharmaceutical compsns of a cephalosporin antibiotic
Orchid Health Care 1534246*
Methods for coating substrates for pharmaceutical uses with a mixture of two film-forming coating agents
Roehm 1534247*
Lasofoxifene tablet and its coating
Pfizer Products 1534248*
Chewable soft capsule
RP Scherer Technologies 1534249*
Electrospun amorphous pharmaceutical compsns
SmithKline Beecham 1534250*
Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
Eurand Pharmaceuticals 1534251*
Breath freshening and oral cleansing product using cardamom oil
WM Wrigley 1534252*
Process for making orally consumable dosage forms
Pfizer 1534253*
Method for promoting smoking cessation
Pharmacia & Upjohn 1534254*
Processes for preparing 1,3-dioxolane nucleosides
Pharmasset 1534255*
Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
Philadelphia Health & Education Corp 1534256*
Co-ordinated palladium compounds having coordinated thereto bis(diphenylphosphine) ferrocene ligands which inhibit the activity of proteins and enzymes and treatment of diseases and disorders associated therewith
Funacao de Amparo a Pesquisa do Estado de Sao Paolo 1534257*
Agonism of the 5HT 2A receptor for treatment of thermoregulatory dysfunction
Wyeth 1534258*
Sulphonamides as potassium channel blockers
Icagen 1534259*
Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation
CXR Biosciences 1534260*
EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
Advanced Vision Research 1534261*
Combination of chemotherapeutic drugs for increasing antitumour activity
Titan Pharmaceuticals 1534262*
Novel compounds, pharmaceutical compsns containing same, and methods of use for same
Fasgen; The Johns Hopkins University 1543263*
Compounds that modulate the activity of PTP-1B and TC-PTP
Sunesis Pharmaceuticals 1534264*
Combination of an aromatase inhibitor with a bisphosphonate
Novartis 1534265*
Colour-stable, low impurity tocopherol compsns and processes for preparing the same
Cognis Corp 1534266*
Pyrrolidine derivatives as tryptase inhibitors
ALTANA Pharma 1534267*
Tyrosine kinase inhibitors
Merck 1534268*
Oxime conjugates and methods for their formulation and use
The General Hospital Corp 1534269*
Carvediol phosphate salts and/or solvates thereof, corresponding compsns, an/or methods of treatment
SB Pharma Puerto Rico 1534270*
Antitumour compound and therapeutic uses thereof
Cell Therapeutics Europe; Instituto Nazionale per Lo Studio Tumori 1534271*
Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors
Elbion 1534272*
Modulators of the glucocorticoid receptor and method
Bristol-Myers Squibb 1534273*
Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib
Warner-Lambert 1534274*
Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
Aventis Pharma Deutschland 1543275*
Non-nucleoside reverse transcriptase inhibitors
Medivir 1534276*
Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
Aventis Pharma Deutschland 1534277*
Nitrosated proton pump inhibitors, compsns and methods of use
Nitromed 1534278*
Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
PPD Discovery 1543279*
Aryl piperidine derivatives and use thereof to reduce elevated levels of LDL-cholesterol
Glaxo Group 1534280*
N-sulphonylpiperidines as metalloproteinase inhibitors (TACE)
AstraZeneca 1534281*
Pharmaceutical compsns of anticholinergics and P38 kinase inhibitors in the treatment of repiratory diseases
Boehringer Ingelheim Pharma 1534282*
Formulation of liposomal derivatives of phenylalanine
Wilex 1534283*
Amino-substituted sulphonanilides and derivatives thereof for treating proliferative disorders
Temple University of the Commonwealth System of Higher Education 1534284*
Selective phosphodiesterase 9A inhibitors as medicaments for improving cognitive processes
Bayer HealthCare 1534285*
Methods of treating or preventing autoimmune diseases with 2m4-pyrimidinediamine compounds
Rigel Pharmaceuticals 1534286*
Combination of ZD6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer
AstraZeneca 1534287*
Stable aqueous solutions of risperidone and methods for their preparation
Ranbaxy Laboratories 1534288*
Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
Kyowa Hakko Kogyo 1534289*
Novel inhibitors of kinases
Bristol-Myers Squibb 1534290*
2-(phenoxymethyl)- and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
Eli Lilly 1534291*
Protease inhibitors
SmithKline Beecham 1534292*
Anti-inflammatory compsns and methods of use
Chemcentryx 1534293*
Broad-spectrum anti-emetic compsns and associated methods
Upchuck 1534294*
Formulations and methods of administration of cephalotaxines, including homoharringtonine
Chemgenex Therapeutics 1534295*
Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
Boehringer Ingelheim Pharmaceuticals 1534296*
Methods of treatment of male erectile dysfunction
Nexmed Holdings 1534297*
Novel anticholesterol compsns and methods for using the same
Anagen Therapeutics 1534298*
Methods for treating psychosis associated with interleukin-alpha therapy
Corcept Therapeutics 1534299*
3, 10, and 12A substituted tetracycline compounds
Paratek Pharmaceuticals 1534300*
Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics
Board of Regents of the University of Texas System 1534301*
Arginine silicate inositol complex and use thereof
Nutrition 21 1534302*
Antimicrobial charged polymers that exhibit resistance to lysomal degradation during kidney filtration and renal passage, compsns and method of use thereof
Monash University 1534303*
An analgesic agent or newborn fetal subjects
Protexeon 1534304*
Treating cartilage/bone conditions with water-soluble strontium salts
Osteologix 1534305*
Defensins: use as antiviral agents
Ciphergen Biosystems; Aaron Diamond AIDS Research Centre 1534306*
Zooplankton enrichment with probionts and prebionts and uses thereof
Advanced Bionutrition 1534307*
Peptides with growth inhibitory action
Becton, Dickinson & Co 1534308*
Parathyroid hormone antagonists and uses thereof
Scantibodies Laboratory 1534309*
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
Tel Aviv University Future Technology Development 1534310*
Method for identifying modulators of ion channels
Janssen Pharmaceutica 1534311*
Intrathecal and intratumoral superantigens to treat malignant disease
Terman, David 1534312*
Ophthalmologic irrigation solutions and method
Omeros Corp 1534313*
A nutrition and therapeutic composition of an insulin sensitiser and a peptide fraction
DSM 1534314*
Increasing of the resorption of substances via skin and mucous membranes
Procom Biotechnologische Produktion 1534315*
Glycopeptide antibodies and semi-synthetic derivatives thereof and their use as antiviral agents
KU Leuven Research and Development 1534316*
N-terminally truncated galectin-23 and antibodies for treating cancer
Mandalmed 1534317*
Methods and compsns for manipulating the guided navigation of endothelial tubes during angiogenesis
The University of Utah Research Foundation 1534318*
Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease
Sema 1534319*
Apoliprotein L-1 for the treatment or diagnosis of trypanosomal diseases
Universite Libre de Bruxelles 1534320*
Methods of use of compounds with preptin function
Protemix Corp 1534321*
Minibrain homologous proteins involved in the regulation of energy homeostasis
DeveloGen Aktiengesellschaft fuer entwicklungbiologische Forschung 1534322*
IL-4 vaccine for the treatment of asthma and atopic disorders
Glaxo Group 1534323*
Tumour specific oligosaccharide epitopes and use thereof
BioTie Therapies 1534324*
Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes
Chiron Corp 1534325*
Combination of VEGF receptor tyrosine kinase inhibitors for treatment of cancer
AstraZeneca 1534338*
Topical anhydrous and ethanol-free ascomycin compsns
Novartis 1534339*
Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
Insert Therapeutics 1534340*
Therapeutic system targeting pathogen proteases and uses thereof
KMT Hepatech 1534341*
Modified saccharides, conjugates thereof and their manufacture
Chiron 1534342*
Non-glycosylated polyacrylamide conjugates and their use for cytoprotection
University of Bern; Shemyakin and Ovchinnikov Institute of Biological Chemistry 1534343*
Viruses and virus-like particles for multiple antigen and target display
Advanced Bionutrition; Allnutt, Thomas F; Kyle, David 1534344*
Method and device for inducing biological process by micro-organs
Yissum Research Development Company of the Hebrew University of Jerusalem 1534345*
Toludine blue O drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues
Zila 1534346*
Conjugates of N-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
Psimei Pharmaceuticals 1534347*